PowerVision, Inc. is a private company focused on developing a novel accommodating intraocular lens, which, it believes, will be the first to restore True Accommodation. Its innovative FluidVision accommodating intraocular lens (IOL) aims to restore the vision of youth to older individuals affected by presbyopia and/or cataracts. PowerVision's mission is to provide a family of fluid-based lens implants that meet the clinical and lifestyle needs caused by these conditions, and develop the most significant innovation in vision correction surgery since the introduction of the intraocular lens. The FluidVision lens is an investigational device that is not available for sale and is available for use only by the investigators participating in the multi-center clinical study.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/24/12 | $37,200,000 | Series C |
Advanced Technology Ventures Frazier Healthcare Johnson & Johnson Innovation Venrock | undisclosed |
| 06/17/14 | $30,000,000 | Series D |
Aisling Capital Correlation Ventures Venrock | undisclosed |
